August 08, 2023
Fusion Pharmaceuticals Announces Second Quarter 2023 Financial Results And Clinical Program Updates
Media
August 07, 2023
Sofia Heigis appointed CEO of Oncopeptides AB (publ)
August 03, 2023
Invitation to presentation of the Q2 report 2023
August 02, 2023
Pulmonx Reports Second Quarter 2023 Financial Results
July 13, 2023
Vicore announces the appointment of Ahmed Mousa as CEO
July 05, 2023
Vicore announces CEO recruitment process
July 03, 2023
Q2 2023 General Market Overview
June 29, 2023
BONESUPPORT launches next generation of CERAMENT® G
June 28, 2023
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors
June 26, 2023
Hemab Therapeutics Presents New Preclinical Research Demonstrating Effects of Its Bispecific Antibody HMB-001 in Factor VII Deficiency